ArticleAlzheimer's & dementia (New York, N. Y.)

Blood-based biomarker prescreening with different testing combinations and cutoffs: A simulation study examining efficacy and cost-effectiveness in Alzheimer's disease prevention studies.

Kenichiro Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.